SPDR S&P Biotech ETF Stock Forecast, Price & News

Wall Street analysts have given SPDR S&P Biotech ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SPDR S&P Biotech ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, XBI shares have increased by 63.0% and is now trading at $128.76.
View which stocks have been most impacted by COVID-19.

SPDR S&P Biotech ETF pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.23%.
View SPDR S&P Biotech ETF's dividend history.

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Nasdaq Biotechnology ETF (IBB), The Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

SPDR S&P Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Jefferies Group LLC (0.00%), Toronto Dominion Bank (11.63%), Toronto Dominion Bank (11.70%), JPMorgan Chase & Co. (8.30%), Morgan Stanley (7.23%) and Healthcare of Ontario Pension Plan Trust Fund (6.67%).

XBI stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Healthcare of Ontario Pension Plan Trust Fund, JPMorgan Chase & Co., GSB Wealth Management LLC, Ikarian Capital LLC, Parallax Volatility Advisers L.P., Point72 Asset Management L.P., and Goldman Sachs Group Inc..

XBI stock was purchased by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Toronto Dominion Bank, Toronto Dominion Bank, Laurion Capital Management LP, Canada Pension Plan Investment Board, Bank of America Corp DE, Bank of America Corp DE, and Millennium Management LLC.

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XBI stock can currently be purchased for approximately $128.76.

SPDR S&P Biotech ETF has a market capitalization of $6.66 billion.

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

SPDR S&P Biotech ETF is headquartered at One Lincoln Street, Boston, 02111, United States.

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.